Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.

Friedman, Claire F

Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition. [electronic resource] - Current oncology reports Apr 2016 - 21 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1534-6269

10.1007/s11912-016-0509-x doi


Antibodies--immunology
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
B7-H1 Antigen--blood
Biomarkers, Tumor--blood
CTLA-4 Antigen--blood
Humans
Immunotherapy
Ipilimumab
Melanoma--blood
Nivolumab
Programmed Cell Death 1 Receptor--blood
Tumor Microenvironment--immunology